BRIGHAM AND WOMENS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $496M
- Transactions
- 13,947
- Companies
- 40
- Average per transaction
- $35,563
Who reported the payments
| AstraZeneca | $54,726,119 |
| Amgen | $48,403,139 |
| Pfizer | $43,400,758 |
| Kowa Holdings America, Inc. | $28,252,156 |
| KOWA Company, LTD. | $24,985,102 |
| E.r. Squibb & Sons, L.L.C. | $21,865,090 |
| Genentech, Inc. | $18,890,832 |
| Astrazeneca UK Limited | $16,520,340 |
| Merck | $14,283,735 |
| Kowa Research Institute, Inc. | $13,600,000 |
| Gilead | $11,930,305 |
| Abbott | $10,774,906 |
| Alnylam Pharmaceuticals Inc. | $10,336,144 |
| Eli Lilly | $9,535,922 |
| Novartis | $6,914,289 |
| Janssen Research & Development, LLC | $6,720,716 |
| Boehringer Ingelheim | $6,410,604 |
| Sanofi US Services Inc. | $5,896,111 |
| Modernatx, Inc. | $5,254,039 |
| Novo Nordisk AS | $5,098,861 |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,976,140 |
| UCB SA | $4,646,724 |
| AbbVie | $4,615,624 |
| Biogen | $4,357,731 |
| Jazz Pharmaceuticals Inc. | $4,327,032 |
| Insightec,ltd | $4,197,732 |
| Canon Medical Systems Corporation | $4,136,467 |
| Boston Scientific | $4,034,476 |
| Siemens Medical Solutions USA, Inc. | $3,747,495 |
| Regeneron | $3,555,016 |
| Eisai Inc. | $3,530,371 |
| Novo Nordisk | $3,497,876 |
| Sanofi | $3,264,963 |
| Bayer | $3,254,356 |
| Blueprint Medicines Corporation | $3,212,310 |
| Bioverativ Therapeutics Inc. | $3,149,736 |
| Novartis Pharma AG | $3,092,950 |
| Vertex | $2,896,204 |
| Amarin Pharma, Inc. | $2,644,968 |
| Edwards Lifesciences | $2,613,168 |